In vitro studies demonstrated that AOD-9604 promotes proteoglycan and collagen production in chondrocyte cultures
Most experts recommend using it in the evening, as some formulations can increase photosensitivity
However, requests that require additional clinical documentation or peer review can extend to 14 days or beyond
As an FDA-approved treatment, Wegovy is a once-weekly injection suitable for adults living with obesity (BMI of 30 or higher) or overweight (BMI of 27 or higher with weight-related conditions)
doi: 10.1210/en.2011-1070 59 HarkavyiAWhittonPS
Pharmacol Rep 66:169173 Dungan KM, Povedano ST, Forst T, Gonzlez JGG, Atisso C, Sealls W, Fahrbach JL (2014) Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial